Keyphrases
Hypertension
100%
Peroxisome Proliferator-activated Receptor
100%
Type 2 Diabetes Mellitus (T2DM)
33%
Glucose Homeostasis
16%
Protective Effect
16%
Myocardial Infarction
16%
Management Strategy
16%
Cardiovascular Disease
16%
High-affinity Ligands
16%
Drug Use
16%
Drug Class
16%
Disease Mechanisms
16%
Novel Mechanism
16%
Hypertensive
16%
Type 2 Diabetic Patients
16%
Antihypertensive Drugs
16%
Cause of Disease
16%
Cardiovascular System
16%
Complex Disorders
16%
Adipocyte Differentiation
16%
Anti-inflammatory Effect
16%
Type 2 Diabetes Prevention
16%
Ongoing Clinical Trials
16%
Thiazolidinediones
16%
Cardiovascular Events
16%
Ligand-activated Transcription Factors
16%
Nuclear Receptor Superfamily
16%
Cardiovascular Risk Management
16%
Proper Management
16%
Novel Management
16%
Chronic Disorders
16%
Anti-atherosclerosis
16%
Anti-atherogenic Effect
16%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
100%
Peroxisome Proliferator Activated Receptor
100%
Disease
66%
Antihypertensive Agent
33%
Anti-Inflammatory Drug
33%
Non Insulin Dependent Diabetes Mellitus
33%
Cardiovascular Disease
33%
Clinical Trial
16%
Heart Infarction
16%
Transcription Factors
16%
Cell Nucleus Receptor
16%
Thiazolidinedione
16%
Cerebrovascular Accident
16%